ASXL1 and acute myeloid leukemia: However, in their cohort of patients, there was a prevalence of the secondary-type mutations in ASXL1 and U2AF1 in NPM1mut AML-MRC-H compared to NPM1mut NK-AML, whereas in our group there was no mutation that stood out, but rather a more equal representation of all mutations.